Faralimomab Explained

Faralimomab is a mouse monoclonal antibody and an immunomodulator.[1] [2]

Notes and References

  1. Web site: WHO Drug Information . 2009-09-24 . https://web.archive.org/web/20110604232719/http://whqlibdoc.who.int/inn/proposed_lists/prop_INN_list76.pdf . 2011-06-04 . dead .
  2. Book: Pelletier JP, Mukhtar F . Chapter 16 - Passive Monoclonal and Polyclonal Antibody Therapies . Maitta RW . Immunologic Concepts in Transfusion Medicine . 2020 . Elsevier . Philadelphia . 978-0-323-67510-9 . 10.1016/B978-0-323-67509-3.00016-0 . 286. 213508934 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Faralimomab".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.